Skip to main content

Table 1 Baseline clinicopathologic variables of African American and Caucasian American patients and tumors utilized for BAC-based DNA copy number analysis and gene expression profiling

From: Copy number and gene expression differences between African American and Caucasian American prostate cancer

  African American(n = 20) Caucasian American(n = 21)*
Age (years)   
   50-54 7 (35%) 5 (24%)
   55-59 6 (30%) 10 (48%)
   60-64 2 (10%) 3 (14%)
   ≥65 5 (25%) 3 (14%)
PSA   
   Mean, SD 8.5, 3.5 8.3, 4.0
   Range 4-17 3-17
Stage   
   II 12 (60%) 16 (76%)
   ≥III 8 (40%) 5 (24%)
Gleason score   
   <7 3 (15%) 6 (29%)
   =7 16 (80%) 11 (52%)
   >7 1 (5%) 4 (19%)
  1. *41 tumors were utilized for BAC array (AA = 20, CA = 21); 33 of the 41 (AA = 19, CA = 14) were also utilized for gene expression.